Compare NEOG & HROW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NEOG | HROW |
|---|---|---|
| Founded | 1981 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.4B |
| IPO Year | 1989 | N/A |
| Metric | NEOG | HROW |
|---|---|---|
| Price | $7.03 | $48.45 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 4 | 8 |
| Target Price | $8.83 | ★ $68.86 |
| AVG Volume (30 Days) | ★ 3.4M | 562.9K |
| Earning Date | 01-08-2026 | 11-10-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $886,886,000.00 | $250,042,000.00 |
| Revenue This Year | N/A | $38.96 |
| Revenue Next Year | $1.80 | $43.38 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 47.83 |
| 52 Week Low | $3.87 | $20.85 |
| 52 Week High | $13.41 | $51.53 |
| Indicator | NEOG | HROW |
|---|---|---|
| Relative Strength Index (RSI) | 58.67 | 58.51 |
| Support Level | $7.01 | $44.19 |
| Resistance Level | $7.29 | $51.53 |
| Average True Range (ATR) | 0.25 | 2.31 |
| MACD | -0.03 | -0.08 |
| Stochastic Oscillator | 41.19 | 62.95 |
Neogen Corporation, headquartered in Lansing, Michigan, develops, manufactures, and markets various products for food and animal safety. In food safety, the company performs diagnostics to detect unintended substances in food and animal feed, to prevent contamination and foodborne illnesses such as foodborne pathogens, spoilage organisms, natural toxins, food allergens, and ruminant by-products. In animal safety, the company segment is engaged in the development, manufacture, marketing and distribution of veterinary instruments, pharmaceuticals, vaccines, topicals, parasiticides, diagnostic products, rodent control products, cleaners, disinfectants, insect control products and genomics testing services.
Harrow Inc is an eyecare pharmaceutical company engaged in the discovery, development, and commercialization of ophthalmic pharmaceutical products for the U.S. market. The company helps U.S. eyecare professionals preserve the gift of sight by making its comprehensive portfolio of prescription and non-prescription pharmaceutical products accessible and affordable to millions of Americans. Its operating segments are The Branded segment includes activities of the Company's FDA-approved ophthalmology pharmaceutical products, including the out-licensing of rights to certain of branded products; and The ImprimisRx segment represents activities in the Company's ophthalmology-focused pharmaceutical compounding business.